For the Inventor, By the Inventor

Enter assignee name

Reykjavik, Iceland

Decode Genetics Ehf

USPTO Granted Patents = 49

% Expired Patents = 69.4

CIPO Patents = 2

EPO Patents = 16

Forward Citations = 450

Loading Chart...

Loading Chart...

71 inventors (with patents filed for the assignee):

Mark E Gurney (16 out of 59 patents)

Jasbir Singh (13 out of 29 patents)

Vincent Premaratna Sandanayaka (11 out of 41 patents)

4. Patrick Sulem (7 out of 7 patents)

5. Hakon Gudbjartsson (7 out of 7 patents)

6. Hakon Hakonarson (5 out of 47 patents)

7. Anna Helgadottir (5 out of 5 patents)

8. Peng Yu (5 out of 5 patents)

9. Jeffrey R Gulcher (5 out of 5 patents)

10. Agust Sverrir Egilsson (5 out of 5 patents)

11. Daniel Gudbjartsson (4 out of 4 patents)

12. Lei Zhao (4 out of 10 patents)

13. Alexander Kiselyov (3 out of 11 patents)

14. Georgeta Hategan (3 out of 13 patents)

15. David E Zembower (3 out of 15 patents)

Core Competencies:

Genetic Susceptibility

Cardiovascular Disease

Breast Cancer Risk

Inflammatory Disorders

Prostate Cancer

Diabetes Mellitus

Atrial Fibrillation

Cancer Predisposition

Myocardial Infarction

LTA4H Inhibitors

Risk Assessment

Gene Markers

49 patents: Sort by Forward Citations

1. 9617597 - Genetic susceptibility variants associated with cardiovascular disease (2017-04-11),

2. 8951735 - Genetic variants for breast cancer risk assessment (2015-02-10),

3. 8883833 - Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders (2014-11-11),

4. 8877816 - 4-(or 5-) substituted catechol derivatives (2014-11-04),

5. 8865400 - Genetic variants contributing to risk of prostate cancer (2014-10-21),

6. 8828657 - Susceptibility variants for lung cancer (2014-09-09),

7. 8808985 - Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm (2014-08-19),

8. 8796182 - Genetic markers associated with risk of diabetes mellitus (2014-08-05),

9. 8795963 - Genetic markers for risk management of atrial fibrillation and stroke (2014-08-05),

10. 8791267 - Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders (2014-07-29),

11. 8697360 - Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition (2014-04-15),

12. 8637244 - Genetic markers for risk management of atrial fibrillation, atrial flutter, and stroke (2014-01-28),

13. 8598359 - Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation (2013-12-03),

14. 8580501 - Genetic variants on chr 5p12 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment (2013-11-12),

15. 8367333 - Genetic variants as markers for use in diagnosis, prognosis and treatment of eosinophilia, asthma, and myocardial infarction (2013-02-05),

Company Overview

Decode Genetics Ehf, based in Reykjavik, Iceland, specializes in the research and development of genetic insights related to various health conditions. The company focuses on identifying genetic susceptibility variants associated with cardiovascular diseases, breast cancer, inflammatory disorders, prostate cancer risk, diabetes mellitus, and atrial fibrillation. By leveraging advanced genetic analysis, Decode Genetics aims to enhance risk assessment and therapeutic strategies, contributing to personalized medicine and improved health outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

49 Patents

#3 in Reykjavik

#3 in Iceland

#14,277 in the World

Reykjavik, Iceland

Decode Genetics Ehf

Forward Citations = 450

71 inventors:

Mark E Gurney (16 out of 59 patents)

Jasbir Singh (13 out of 29 patents)

Vincent Premaratna Sandanayaka (11 out of 41 patents)

4. Patrick Sulem (7 out of 7 patents)

5. Hakon Gudbjartsson (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Decode Genetics Ehf. Retrieved from https://idiyas.com/company/decode-genetics-ehf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…